Статті в журналах з теми "ApoL9"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "ApoL9".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Hawkins, Gregory A., David J. Friedman, Lingyi Lu, David R. McWilliams, Jeff W. Chou, Satria Sajuthi, Jasmin Divers, et al. "Re-Sequencing of the APOL1-APOL4 and MYH9 Gene Regions in African Americans Does Not Identify Additional Risks for CKD Progression." American Journal of Nephrology 42, no. 2 (2015): 99–106. http://dx.doi.org/10.1159/000439448.
Повний текст джерелаScales, Suzie J., Nidhi Gupta, Ann M. De Mazière, George Posthuma, Cecilia P. Chiu, Andrew A. Pierce, Kathy Hötzel, et al. "Apolipoprotein L1-Specific Antibodies Detect Endogenous APOL1 inside the Endoplasmic Reticulum and on the Plasma Membrane of Podocytes." Journal of the American Society of Nephrology 31, no. 9 (August 6, 2020): 2044–64. http://dx.doi.org/10.1681/asn.2019080829.
Повний текст джерелаChen, Teresa K., Aditya L. Surapaneni, Dan E. Arking, Christie M. Ballantyne, Eric Boerwinkle, Jingsha Chen, Josef Coresh, et al. "APOL1 Kidney Risk Variants and Proteomics." Clinical Journal of the American Society of Nephrology 17, no. 5 (April 26, 2022): 684–92. http://dx.doi.org/10.2215/cjn.14701121.
Повний текст джерелаArunmanee, Wanatchaporn, Richard K. Heenan, and Jeremy H. Lakey. "Determining the amphipol distribution within membrane-protein fibre samples using small-angle neutron scattering." Acta Crystallographica Section D Structural Biology 74, no. 12 (November 30, 2018): 1192–99. http://dx.doi.org/10.1107/s205979831800476x.
Повний текст джерелаAnderson, Blair R., Erica E. Davis, Marilyn J. Telen, and Allison E. Ashley-Koch. "In Vivo Modeling Of Genetic Mechanisms Associated With Sickle Cell Disease Nephropathy." Blood 122, no. 21 (November 15, 2013): 2224. http://dx.doi.org/10.1182/blood.v122.21.2224.2224.
Повний текст джерелаWang, Zhixing, and Fan Wang. "Identification of Ten-Gene Related to Lipid Metabolism for Predicting Overall Survival of Breast Invasive Carcinoma." Contrast Media & Molecular Imaging 2022 (July 11, 2022): 1–16. http://dx.doi.org/10.1155/2022/8348780.
Повний текст джерелаUzureau, Sophie, Laurence Lecordier, Pierrick Uzureau, Dorle Hennig, Jonas H. Graversen, Fabrice Homblé, Pepe Ekulu Mfutu, et al. "APOL1 C-Terminal Variants May Trigger Kidney Disease through Interference with APOL3 Control of Actomyosin." Cell Reports 30, no. 11 (March 2020): 3821–36. http://dx.doi.org/10.1016/j.celrep.2020.02.064.
Повний текст джерелаHeneghan, J. F., D. H. Vandorpe, B. E. Shmukler, J. A. Giovinazzo, J. Raper, D. J. Friedman, M. R. Pollak, and S. L. Alper. "BH3 domain-independent apolipoprotein L1 toxicity rescued by BCL2 prosurvival proteins." American Journal of Physiology-Cell Physiology 309, no. 5 (September 1, 2015): C332—C347. http://dx.doi.org/10.1152/ajpcell.00142.2015.
Повний текст джерелаBlessing, Natalya A., Zhenzhen Wu, Sethu M. Madhavan, Jonathan W. Choy, Michelle Chen, Myung K. Shin, Maarten Hoek, John R. Sedor, John F. O’Toole, and Leslie A. Bruggeman. "Lack of APOL1 in proximal tubules of normal human kidneys and proteinuric APOL1 transgenic mouse kidneys." PLOS ONE 16, no. 6 (June 17, 2021): e0253197. http://dx.doi.org/10.1371/journal.pone.0253197.
Повний текст джерелаPratt, Cindy C., and Paul M. M. Weers. "Lipopolysaccharide binding of an exchangeable apolipoprotein, apolipophorin III, from Galleria mellonella." Biological Chemistry 385, no. 11 (November 1, 2004): 1113–19. http://dx.doi.org/10.1515/bc.2004.145.
Повний текст джерелаGordon, Elisa J., Daniela Amórtegui, Isaac Blancas, Catherine Wicklund, John Friedewald, and Richard R. Sharp. "A Focus Group Study on African American Living Donors’ Treatment Preferences, Sociocultural Factors, and Health Beliefs About Apolipoprotein L1 Genetic Testing." Progress in Transplantation 29, no. 3 (May 30, 2019): 239–47. http://dx.doi.org/10.1177/1526924819854485.
Повний текст джерелаTzukerman, Maty, Yeela Shamai, Ifat Abramovich, Eyal Gottlieb, Sara Selig, and Karl Skorecki. "Comparative Analysis of the APOL1 Variants in the Genetic Landscape of Renal Carcinoma Cells." Cancers 14, no. 3 (January 30, 2022): 733. http://dx.doi.org/10.3390/cancers14030733.
Повний текст джерелаAndrews, Michael, Teruhiko Yoshida, Clark M. Henderson, Hannah Pflaum, Ayako McGregor, Joshua A. Lieberman, Ian H. de Boer, et al. "Variant APOL1 protein in plasma associates with larger particles in humans and mouse models of kidney injury." PLOS ONE 17, no. 10 (October 24, 2022): e0276649. http://dx.doi.org/10.1371/journal.pone.0276649.
Повний текст джерелаGupta, Nidhi, Xinhua Wang, Xiaohui Wen, Paul Moran, Maciej Paluch, Philip E. Hass, Amy Heidersbach, et al. "Domain-Specific Antibodies Reveal Differences in the Membrane Topologies of Apolipoprotein L1 in Serum and Podocytes." Journal of the American Society of Nephrology 31, no. 9 (August 6, 2020): 2065–82. http://dx.doi.org/10.1681/asn.2019080830.
Повний текст джерелаGordon, Elisa J., Catherine Wicklund, Jungwha Lee, Richard R. Sharp, and John Friedewald. "A National Survey of Transplant Surgeons and Nephrologists on Implementing Apolipoprotein L1 (APOL1) Genetic Testing Into Clinical Practice." Progress in Transplantation 29, no. 1 (December 13, 2018): 26–35. http://dx.doi.org/10.1177/1526924818817048.
Повний текст джерелаChun, Justin, Jia-Yue Zhang, Maris S. Wilkins, Balajikarthick Subramanian, Cristian Riella, Jose M. Magraner, Seth L. Alper, David J. Friedman, and Martin R. Pollak. "Recruitment of APOL1 kidney disease risk variants to lipid droplets attenuates cell toxicity." Proceedings of the National Academy of Sciences 116, no. 9 (February 7, 2019): 3712–21. http://dx.doi.org/10.1073/pnas.1820414116.
Повний текст джерелаCornelissen, Anne, Daniela T. Fuller, Raquel Fernandez, Xiaoqing Zhao, Robert Kutys, Elizabeth Binns-Roemer, Marco Delsante, et al. "APOL1 Genetic Variants Are Associated With Increased Risk of Coronary Atherosclerotic Plaque Rupture in the Black Population." Arteriosclerosis, Thrombosis, and Vascular Biology 41, no. 7 (July 2021): 2201–14. http://dx.doi.org/10.1161/atvbaha.120.315788.
Повний текст джерелаOlabisi, Opeyemi A., Jia-Yue Zhang, Lynn VerPlank, Nathan Zahler, Salvatore DiBartolo, John F. Heneghan, Johannes S. Schlöndorff, et al. "APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases." Proceedings of the National Academy of Sciences 113, no. 4 (December 23, 2015): 830–37. http://dx.doi.org/10.1073/pnas.1522913113.
Повний текст джерелаKumar, Vinod, and Pravin C. Singhal. "APOL1 and kidney cell function." American Journal of Physiology-Renal Physiology 317, no. 2 (August 1, 2019): F463—F477. http://dx.doi.org/10.1152/ajprenal.00233.2019.
Повний текст джерелаEkulu, Pepe M., Oyindamola C. Adebayo, Jean-Paul Decuypere, Linda Bellucci, Mohamed A. Elmonem, Agathe B. Nkoy, Djalila Mekahli, et al. "Novel Human Podocyte Cell Model Carrying G2/G2 APOL1 High-Risk Genotype." Cells 10, no. 8 (July 28, 2021): 1914. http://dx.doi.org/10.3390/cells10081914.
Повний текст джерелаZhang, Jia-Yue, Minxian Wang, Lei Tian, Giulio Genovese, Paul Yan, James G. Wilson, Ravi Thadhani, et al. "UBD modifies APOL1-induced kidney disease risk." Proceedings of the National Academy of Sciences 115, no. 13 (March 12, 2018): 3446–51. http://dx.doi.org/10.1073/pnas.1716113115.
Повний текст джерелаPalusińska-Szysz, Marta, Agnieszka Zdybicka-Barabas, Rafał Luchowski, Emilia Reszczyńska, Justyna Śmiałek, Paweł Mak, Wiesław I. Gruszecki, and Małgorzata Cytryńska. "Choline Supplementation Sensitizes Legionella dumoffii to Galleria mellonella Apolipophorin III." International Journal of Molecular Sciences 21, no. 16 (August 13, 2020): 5818. http://dx.doi.org/10.3390/ijms21165818.
Повний текст джерелаMcIntosh, Tristan, Sumit Mohan, Deirdre Sawinski, Ana Iltis, and James M. DuBois. "Variation of ApoL1 Testing Practices for Living Kidney Donors." Progress in Transplantation 30, no. 1 (December 16, 2019): 22–28. http://dx.doi.org/10.1177/1526924819892917.
Повний текст джерелаKhatua, Atanu K., Amber M. Cheatham, Etty D. Kruzel, Pravin C. Singhal, Karl Skorecki, and Waldemar Popik. "Exon 4-encoded sequence is a major determinant of cytotoxicity of apolipoprotein L1." American Journal of Physiology-Cell Physiology 309, no. 1 (July 1, 2015): C22—C37. http://dx.doi.org/10.1152/ajpcell.00384.2014.
Повний текст джерелаYoung, Bessie A., Erika Blacksher, Kerri L. Cavanaugh, Barry I. Freedman, Stephanie M. Fullerton, Jeffrey B. Kopp, Ebele M. Umeukeje, Kathleen M. West, James G. Wilson, and Wylie Burke. "Apolipoprotein L1 Testing in African Americans: Involving the Community in Policy Discussions." American Journal of Nephrology 50, no. 4 (2019): 303–11. http://dx.doi.org/10.1159/000502675.
Повний текст джерелаAnderson, Blair R., Erica E. Davis, Marilyn J. Telen, and Allison E. Ashley-Koch. "Evidence for a Dominant Negative Effect Conferred By the APOL1 G2 Sickle Cell Nephropathy Risk Allele in an in Vivo Model." Blood 124, no. 21 (December 6, 2014): 1374. http://dx.doi.org/10.1182/blood.v124.21.1374.1374.
Повний текст джерелаZhu, Hua, Xinyao Hu, Shi Feng, Yuntao Li, Yonggang Zhang, Sheng Qiu, Ran Chen, et al. "APOL4, a Novel Immune-Related Prognostic Biomarker for Glioma." Journal of Clinical Medicine 11, no. 19 (September 29, 2022): 5765. http://dx.doi.org/10.3390/jcm11195765.
Повний текст джерелаRaghubeer, Shanel, Tahir S. Pillay, and Tandi Edith Matsha. "Gene of the month: APOL1." Journal of Clinical Pathology 73, no. 8 (May 13, 2020): 441–43. http://dx.doi.org/10.1136/jclinpath-2020-206517.
Повний текст джерелаPalusińska-Szysz, Marta, Agnieszka Zdybicka-Barabas, Magdalena Frąc, Wiesław I. Gruszecki, Sylwia Wdowiak-Wróbel, Emilia Reszczyńska, Dorota Skorupska, Paweł Mak, and Małgorzata Cytryńska. "Identification and characterization of Staphylococcus spp. and their susceptibility to insect apolipophorin III." Future Microbiology 15, no. 11 (July 2020): 1015–32. http://dx.doi.org/10.2217/fmb-2019-0328.
Повний текст джерелаShah, Shrijal S., Herbert Lannon, Leny Dias, Jia-Yue Zhang, Seth L. Alper, Martin R. Pollak, and David J. Friedman. "APOL1 Kidney Risk Variants Induce Cell Death via Mitochondrial Translocation and Opening of the Mitochondrial Permeability Transition Pore." Journal of the American Society of Nephrology 30, no. 12 (September 26, 2019): 2355–68. http://dx.doi.org/10.1681/asn.2019020114.
Повний текст джерелаGe, Mengyuan, Judith Molina, G. Michelle Ducasa, Shamroop K. Mallela, Javier Varona Santos, Alla Mitrofanova, Jin-Ju Kim, et al. "APOL1 risk variants affect podocyte lipid homeostasis and energy production in focal segmental glomerulosclerosis." Human Molecular Genetics 30, no. 3-4 (January 30, 2021): 182–97. http://dx.doi.org/10.1093/hmg/ddab022.
Повний текст джерелаLiu, Esther, Behram Radmanesh, Byungha H. Chung, Michael D. Donnan, Dan Yi, Amal Dadi, Kelly D. Smith, et al. "Profiling APOL1 Nephropathy Risk Variants in Genome-Edited Kidney Organoids with Single-Cell Transcriptomics." Kidney360 1, no. 3 (February 18, 2020): 203–15. http://dx.doi.org/10.34067/kid.0000422019.
Повний текст джерелаThomson, Russell, and Alan Finkelstein. "Human trypanolytic factor APOL1 forms pH-gated cation-selective channels in planar lipid bilayers: Relevance to trypanosome lysis." Proceedings of the National Academy of Sciences 112, no. 9 (February 17, 2015): 2894–99. http://dx.doi.org/10.1073/pnas.1421953112.
Повний текст джерелаAkhavan Sepahi, Mohsen, LVKS Bhaskar, Audrey Tolouian, and Ramin Tolouian. "Apolipoprotein L1 associated nephropathy; an overview." Journal of Renal Injury Prevention 8, no. 4 (November 15, 2019): 311–15. http://dx.doi.org/10.15171/jrip.2019.57.
Повний текст джерелаChaudhary, Ninad S., Justin X. Moore, Neil A. Zakai, Suzanne E. Judd, Rakhi P. Naik, Sophie Limou, Mary Cushman, et al. "APOL1 Nephropathy Risk Alleles and Risk of Sepsis in Blacks." Clinical Journal of the American Society of Nephrology 14, no. 12 (November 8, 2019): 1733–40. http://dx.doi.org/10.2215/cjn.04490419.
Повний текст джерелаBruggeman, Leslie A., John F. O’Toole, and John R. Sedor. "APOL1 polymorphisms and kidney disease: loss-of-function or gain-of-function?" American Journal of Physiology-Renal Physiology 316, no. 1 (January 1, 2019): F1—F8. http://dx.doi.org/10.1152/ajprenal.00426.2018.
Повний текст джерелаWang, Hanghang, Patrick H. Pun, Lydia Kwee, Damian Craig, Carol Haynes, Megan Chryst-Ladd, Laura P. Svetkey, et al. "Apolipoprotein L1 Genetic Variants Are Associated with Chronic Kidney Disease but Not with Cardiovascular Disease in a Population Referred for Cardiac Catheterization." Cardiorenal Medicine 7, no. 2 (December 29, 2016): 96–103. http://dx.doi.org/10.1159/000453458.
Повний текст джерелаDavis, Shamara E., Atanu Khatua, and Waldemar Popik. "Nucleosomal double-stranded DNA triggers APOL1 expression through the STINGTBK1-IRF3 pathway." Journal of Immunology 202, no. 1_Supplement (May 1, 2019): 63.2. http://dx.doi.org/10.4049/jimmunol.202.supp.63.2.
Повний текст джерелаO'Toole, John F., William Schilling, Diana Kunze, Sethu M. Madhavan, Martha Konieczkowski, Yaping Gu, Liping Luo, Zhenzhen Wu, Leslie A. Bruggeman, and John R. Sedor. "ApoL1 Overexpression Drives Variant-Independent Cytotoxicity." Journal of the American Society of Nephrology 29, no. 3 (November 27, 2017): 869–79. http://dx.doi.org/10.1681/asn.2016121322.
Повний текст джерелаZahr, Rima, Jeffrey Lebensburger, Evadnie Rampersaud, Jane S. Hankins, and Jeremie H. Estepp. "Children with Sickle Cell Anemia and APOL1 Gene Variants Develop Albuminuria Early in Life." Blood 132, Supplement 1 (November 29, 2018): 2377. http://dx.doi.org/10.1182/blood-2018-99-118912.
Повний текст джерелаFriedman, David J., and Martin R. Pollak. "APOL1 and Kidney Disease: From Genetics to Biology." Annual Review of Physiology 82, no. 1 (February 10, 2020): 323–42. http://dx.doi.org/10.1146/annurev-physiol-021119-034345.
Повний текст джерелаDoshi, Mona D., Mariella Ortigosa-Goggins, Amit X. Garg, Lihua Li, Emilio D. Poggio, Cheryl A. Winkler, and Jeffrey B. Kopp. "APOL1 Genotype and Renal Function of Black Living Donors." Journal of the American Society of Nephrology 29, no. 4 (January 16, 2018): 1309–16. http://dx.doi.org/10.1681/asn.2017060658.
Повний текст джерелаLee, Hewang, Hila Roshanravan, Ying Wang, Koji Okamoto, Junghwa Ryu, Shashi Shrivastav, Peng Qu, and Jeffrey B. Kopp. "ApoL1 renal risk variants induce aberrant THP-1 monocyte differentiation and increase eicosanoid production via enhanced expression of cyclooxygenase-2." American Journal of Physiology-Renal Physiology 315, no. 1 (July 1, 2018): F140—F150. http://dx.doi.org/10.1152/ajprenal.00254.2017.
Повний текст джерелаShetty, Aneesha A., Ibrahim Tawhari, Luisa Safar-Boueri, Nay Seif, Ameen Alahmadi, Richard Gargiulo, Vikram Aggarwal, et al. "COVID-19–Associated Glomerular Disease." Journal of the American Society of Nephrology 32, no. 1 (November 19, 2020): 33–40. http://dx.doi.org/10.1681/asn.2020060804.
Повний текст джерелаGudsoorkar, Prakash, Manish Anand, and Bassam G. Abu Jawdeh. "APOL1 Genotyping in Potential African American Living Kidney Donors: Utility and Cost-Effectiveness." American Journal of Nephrology 51, no. 2 (2020): 116–18. http://dx.doi.org/10.1159/000505719.
Повний текст джерелаMishra, Abheepsa, Kamesh Ayasolla, Vinod Kumar, Xiqian Lan, Himanshu Vashistha, Rukhsana Aslam, Ali Hussain, et al. "Modulation of apolipoprotein L1-microRNA-193a axis prevents podocyte dedifferentiation in high-glucose milieu." American Journal of Physiology-Renal Physiology 314, no. 5 (May 1, 2018): F832—F843. http://dx.doi.org/10.1152/ajprenal.00541.2017.
Повний текст джерелаValsecchi, Manuela, Valentina Cazzetta, Ferdinando Oriolo, Xiqian Lan, Rocco Piazza, Moin A. Saleem, Pravin C. Singhal, Domenico Mavilio, Joanna Mikulak, and Massimo Aureli. "APOL1 polymorphism modulates sphingolipid profile of human podocytes." Glycoconjugate Journal 37, no. 6 (September 11, 2020): 729–44. http://dx.doi.org/10.1007/s10719-020-09944-w.
Повний текст джерелаReiner, Alex P., and Katalin Susztak. "APOL1 Variants." Arteriosclerosis, Thrombosis, and Vascular Biology 36, no. 2 (February 2016): 219–20. http://dx.doi.org/10.1161/atvbaha.115.306794.
Повний текст джерелаJha, Alok, Shourav Saha, Kamesh Ayasolla, Himanshu Vashistha, Ashwani Malhotra, Karl Skorecki, and Pravin C. Singhal. "MiR193a Modulation and Podocyte Phenotype." Cells 9, no. 4 (April 17, 2020): 1004. http://dx.doi.org/10.3390/cells9041004.
Повний текст джерелаMoodalbail, Divya G., and Bonita Falkner. "Apolipoprotein L1 Genetic Variants Are Associated with Evidence of Early Kidney Injury in Sickle Cell Disease." Blood 130, Suppl_1 (December 7, 2017): 985. http://dx.doi.org/10.1182/blood.v130.suppl_1.985.985.
Повний текст джерела